In breast cancer cells (4T1 and JC cells), fisetin increased HO‐1 mRNA and protein expressions, elevated Nrf2 expression, and abrogated the HO‐1 expression, whereas HO‐1 expression was mediated by up‐regulation of the transcription factor Nrf2. This evidence concerns the gene HMOX1 and breast carcinoma.